Press Releases
IDEAYA and GSK Announce a Broad Partnership in Synthetic Lethality, an Emerging Field in Precision Medicine Oncology
IDEAYA Biosciences, Inc. and GlaxoSmithKline plc announce a strategic partnership in Synthetic Lethality, an emerging field in Oncology.
The strategic partnership includes IDEAYA’s Synthetic Lethality programs MAT2A, Pol Theta, and Werner Helicase programs, which are projected to reach clinical trials...
Press Releases
Pfizer Announced FDA Approval of Oncology Supportive Care Biosimilar, NYVEPRIA
Pfizer Inc. announced the US FDA has approved NYVEPRIA, a biosimilar to Neulasta NYVEPRIA is indicated to decrease the incidence of infection, as manifested by febrile neutropenia, in patients with non-myeloid malignancies receiving myelosuppressive anti-cancer drugs associated with a...
Press Releases
Sunovion Announces Health Canada Approval of KYNMOBI Soluble Film for the Treatment of Parkinson’s Disease OFF Episodes
Sunovion Pharmaceuticals Inc. announced that Health Canada has approved KYNMOBI soluble film for the acute, intermittent treatment of OFF episodes in patients with Parkinson’s disease (PD). OFF episodes are the re-emergence or worsening of PD symptoms otherwise controlled with...
Press Releases
AstraZeneca to Supply Europe with 400M Doses of COVID-19 Vaccine
AstraZeneca has reached an agreement with Europe’s Inclusive Vaccines Alliance (IVA), spearheaded by Germany, France, Italy and the Netherlands, to supply up to 400 million doses of the University of Oxford’s COVID-19 vaccine, with deliveries starting by the end...
Drug Research
Catalent Signs Agreement with AstraZeneca to Manufacture COVID-19 Vaccine Candidate
Catalent, Inc. , the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products, announced that Catalent Biologics will provide vial filling and packaging capacity to AstraZeneca...
Press Releases
Illumina Receives First FDA Emergency Use Authorization for a Sequencing-Based COVID-19 Diagnostic Test
llumina, Inc. is paving the way for large-scale, next-generation sequencing-based (NGS) COVID-19 testing. The U.S. FDA issued an EUA for the Illumina COVIDSeq™ Test, a high-throughput, sequencing-based, in vitro diagnostic (IVD) workflow enabling the detection of SARS-CoV-2. The end-to-end...
Press Releases
CPhI Middle East & Africa to debut in Saudi Arabia in 2021
Informa, the organisers of the leading regional pharmaceutical event CPhI Middle East & Africa, has announced that due to the COVID-19 pandemic, the 2020 edition of the show, scheduled to take place in September in Abu Dhabi, has been...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read